Filing Details

Accession Number:
0001437749-21-014985
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-16 20:30:46
Reporting Period:
2021-06-15
Accepted Time:
2021-06-16 20:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
834365 Biolife Solutions Inc BLFS Electromedical & Electrotherapeutic Apparatus (3845) 943076866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1633186 Todd Berard C/O Biolife Solutions, Inc.
3303 Monte Villa Parkway, Suite 310
Bothell WA 98021
Chief Marketing Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 6,160 $1.64 85,726 No 4 M Direct
Common Stock Disposition 2021-06-15 6,160 $39.38 79,566 No 4 S Direct
Common Stock Acquisiton 2021-06-16 6,160 $1.64 85,726 No 4 M Direct
Common Stock Disposition 2021-06-16 6,160 $39.26 79,566 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Share Option (Right to Buy) Disposition 2021-06-15 6,160 $0.00 6,160 $1.64
Common Stock Share Option (Right to Buy) Disposition 2021-06-16 6,160 $0.00 6,160 $1.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
67,765 2021-12-20 No 4 M Direct
61,605 2021-12-20 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.55 to $39.80 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.92 to $39.70 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
  4. On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.